About this trial
This study aims to explore biomarkers in the endometrial fluid and tissue of women with moderate to severe endometriosis, with a specific focus on those involved in pre-receptive endometrium and embryo implantation. This research has the potential to uncover diagnostic indicators of impaired pre-receptive endometrium, examine pathophysiological pathways, and identify future targets for therapeutic intervention. Ultimately, the findings may contribute to more personalized fertility treatments, offering new hope for women struggling with endometriosis-related infertility.
Eligibility criteria
Qualifiers
Age 18-40 years old
Diagnosed with moderate/severe endometriosis by ultrasound or laparoscopy (patient group)
Regular menstrual cycles 28-35 days
Speak English or Swedish and agree to participate in the study
Disqualifiers
Pregnancy or lactation in the last 3 months
Uterine anomalies
Pelvic inflammatory disease, endometritis, STD
Gynaecological cancers or other malignancies in the patient's history
Trial design
Treatments tested in this trial
- Endometrial fluid
- Endometrial biopsy
- Follicular fluid